Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GarlicRich is a standardized 10:1 garlic concentrate developed and manufactured by Natural Factors, with the trademark held by InovoBiologic. Produced using the proprietary EnviroSimplex process, it is derived from non-GMO, pesticide-free *Allium sativum* bulbs and standardized to maintain high levels of organosulfur compounds, including alliin, allicin, and gamma-glutamylcysteines. While primarily marketed as a dietary supplement for cardiovascular health (reduction of cholesterol and blood pressure) and immune support, it has also been investigated as a topical therapeutic. Specifically, a topical gel formulation of GarlicRich was studied for the treatment of pediatric alopecia areata, hypothesized to exert immunomodulatory effects; however, clinical trials for this indication were terminated. The product's mechanism of action is largely attributed to allicin, which reacts with thiol (sulfhydryl) groups on target enzymes such as HMG-CoA reductase and angiotensin-converting enzyme (ACE), and exhibits broad-spectrum antimicrobial and antioxidant properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GarlicRich.